Adv. Prity Khastgir Delhi High Court IP Litigator

🇮🇳 Protecting multi-million dollar ideas, one brief at a time. Brands built them, I defend them. Design, Patents, Trademarks, & Copyright
📍 New Delhi #IPRs

[Adv. Prity Khastgir Delhi High Court IP Litigator @SWOTLawyer]

💡 Strategic Business Playbook: How Innovator Pharma Survives the Patent Cliff #MarketMonopoly https://t.co/yZSUYgBV11
👇
#Pharmaceuticals #PatentCliff #IntellectualProperty #PharmaInnovation #Generics #HealthcareLaw #Ozempic #Biosimilars #ResearchAndDevelopment #IPR

[Adv. Prity Khastgir Delhi High Court IP Litigator @SWOTLawyer]

#Pharmaceuticals #PatentCliff #IntellectualProperty #PharmaInnovation #Generics #HealthcareLaw #Ozempic #Biosimilars #ResearchAndDevelopment #IPR #IndianPharma #PharmaIndustry #DrugDiscovery #CorporateStrategy #HealthcareBusiness #LegalCompliance #MarketMonopoly #Innovation

[Adv. Prity Khastgir Delhi High Court IP Litigator @SWOTLawyer]

Massive shake-up is brewing in the global pharmaceutical market, and it is happening right at the intersection of molecular engineering and intellectual property law #GLP1 #Semaglutide #WeightLossPill #GenericDrugs #PharmaInnovation #HealthcareRevolution #Biotech #DiabetesCare

[Adv. Prity Khastgir Delhi High Court IP Litigator @SWOTLawyer]

Is this the end of painful weekly injections for millions of diabetes and weight-loss patients worldwide https://t.co/5gg88CQ6Mv via @LinkedIn #GLP1 #Semaglutide #WeightLossPill #GenericDrugs #PharmaInnovation #HealthcareRevolution #Biotech #DiabetesCare #ObesityTreatment

[Adv. Prity Khastgir Delhi High Court IP Litigator @SWOTLawyer]

💊Oral GLP-1 Revolution Just Got a Major Boost in India
A game-changing patent design-around could soon bring affordable, oral weight-loss and diabetes generic formulations to millions, entirely skipping the hassle of painful weekly injections #GLP1 #Semaglutide #WeightLossPill